Tiny particles supercharge radiation to fight esophageal cancer
NCT ID NCT04615013
Summary
This early-stage study is testing a new nanoparticle treatment called NBTXR3 for people with esophageal cancer. The nanoparticles are injected directly into the tumor and are designed to make radiation therapy more effective at killing cancer cells when combined with standard chemotherapy. The main goals are to find the safest and most effective dose and to see how well patients tolerate this new combination approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.